Fundraising Fox
Kevin McBride
InvestorGeneral Partner and Chief Scientific Officer at AmorChem
Find your path to Kevin
Sign up to see every warm intro you have to Kevin
- Paths you didn't know you had: your email and LinkedIn already hold routes to Kevin. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Kevin McBride is General Partner and CSO of AmorChem, where he provides scientific oversight for the AmorChem II portfolio and serves as acting CEO of ARNA Therapeutics. He joined AmorChem in 2013 as Director of Project Management before becoming Vice President, Research, and previously spent 25 years in university research and the biotechnology industry, helping create and lead R&D at companies including Compatigène and Chronogen. He holds an MSc in analytical chemistry from Queen's University, Belfast, a PhD in biochemistry from the University of London School of Pharmacy, and completed postdoctoral work at the Institut de recherches cliniques de Montréal.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Investor
ARNA TherapeuticsFairhaven PharmaceuticalsMperia Therapeutics
Per the firm's website.
Colleagues at AmorChem
Frequently asked questions
- Who is Kevin McBride?
- Kevin McBride is General Partner and CSO of AmorChem, where he provides scientific oversight for the AmorChem II portfolio and serves as acting CEO of ARNA Therapeutics. He joined AmorChem in 2013 as Director of Project Management before becoming Vice President, Research, and previously spent 25 years in university research and the biotechnology industry, helping create and lead R&D at companies including Compatigène and Chronogen. He holds an MSc in analytical chemistry from Queen's University, Belfast, a PhD in biochemistry from the University of London School of Pharmacy, and completed postdoctoral work at the Institut de recherches cliniques de Montréal.
- Where does Kevin McBride work?
- Kevin McBride is General Partner and Chief Scientific Officer at AmorChem.
- What does Kevin McBride invest in?
- Kevin McBride invests in Biotech.
- What companies has Kevin McBride invested in?
- Investments tracked here include ARNA Therapeutics, Fairhaven Pharmaceuticals, Mperia Therapeutics.
About this profile. Compiled from public sources — AmorChem's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights